Detailed price information for Energy Transfer LP (ET-N) from The Globe and Mail including charting and trades.
MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company's First FDA-Approv ...
Getting ready for the longest night of the yearThe first day of winter will be Sunday as the winter solstice begins. On that ...
The US Food and Drug Administration (FDA) has approved Cytokinetics’ Myqorzo (aficamten) for the treatment of adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results